Ganciclovir
Hematologic Toxicity, Impairment of Fertility, Fetal Toxicity, Mutagenesis and Carcinogenesis
Hematologic Toxocity
- Granulocytopenia, anemia and thrombocytopenia, and pancytopenia have been reported in patients treated with ganciclovir.
Impairment of Fertility
- Based on animal data and limited human data, ganciclovir may cause temporary or permanent inhibition of spermatogenesis in males and suppression of fertility in females.
Fetal Toxicity
- Based on animal data, ganciclovir has the potential to cause birth defects in humans.
Mutagenesis and Carcinogenesis
- Based on animal data, gancyclovir has the potential to cause cancers in humans.
Indications
- IV and oral products have specific indications (see package insert)
Oral Capsules
- Associated with risk of rapid rate of CMV retinitis progression and should be used as maintenance therapy only in patients who benefit from avoiding daily intravenous infusions.
Monitoring data
- Frequent complete blood counts and platelet counts performed, especially in patients with previous hematological reactions with this drug or other nucleoside analogues.
Patient counseling
Package inserts
Additional information
Updated: September 2018